Webinar: SeqCap EZ Exomes, Cancer and Neurology Designs


Next generation sequencing promises to revolutionize cancer research, diagnostic and therapeutic applications. Whole-genome, whole-exome and target sequencing approaches have provided dramatic insights toward cancer related genomic alterations, including point mutations, insertions, deletions, copy number alterations and structural variations. By comprehensively understanding these genetic alterations, researchers are able to identify somatic and germ line variations driving cancer susceptibility, development, progression and treatment selection, which may make a difference in cancer management.